<!DOCTYPE html>
<html lang="en">
<head>
  <!-- Google tag (gtag.js) -->
  <script async src="https://www.googletagmanager.com/gtag/js?id=G-LSRR4KW715"></script>
  <script>
    window.dataLayer = window.dataLayer || [];
    function gtag(){dataLayer.push(arguments);
    }
    gtag('js', new Date());

    gtag('config', 'G-LSRR4KW715');
  </script>


  <meta charset="UTF-8" />
  <meta name="viewport" content="width=device-width, initial-scale=1.0" />
  <title>Case 29.8 - Unplanned Pregnancy & Contraception [SDL]</title>

  <!-- Favicon -->
  <link rel="icon" type="image/png" href="../assets/ShepTech logo.png">
  <link rel="apple-touch-icon" href="../assets/ShepTech logo.png">

  <!-- Primary Meta Tags -->
  <meta name="title" content="Case 29.8 - Unplanned Pregnancy & Contraception [SDL] | MD3 SCP Cases">
  <meta name="description" content="Self-directed learning case on unplanned pregnancy covering emergency contraception, medical abortion, surgical abortion, and Fraser competence.">

  <!-- Open Graph / Facebook -->
  <meta property="fb:app_id" content="your_facebook_app_id">
  <meta property="og:type" content="article">
  <meta property="og:url" content="https://md3-scp.netlify.app/cases/case29_8.html">
  <meta property="og:title" content="Case 29.8 - Unplanned Pregnancy & Contraception [SDL]">
  <meta property="og:site_name" content="MD3 SCP Cases">
  <meta property="og:description" content="Self-directed learning case on unplanned pregnancy covering emergency contraception, medical abortion, surgical abortion, and Fraser competence.">
  <meta property="og:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">
  <!-- Twitter -->
  <meta property="twitter:card" content="summary">
  <meta property="twitter:title" content="Case 29.8 - Unplanned Pregnancy & Contraception [SDL]">
  <meta property="twitter:description" content="Self-directed learning case on unplanned pregnancy covering emergency contraception, medical abortion, surgical abortion, and Fraser competence.">
  <meta property="twitter:image" content="https://md3-scp.netlify.app/assets/ShepTech%20logo.png">

  <link rel="stylesheet" href="../css/case.css">

  <!-- Firebase SDK -->
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-app-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-auth-compat.js"></script>
  <script src="https://www.gstatic.com/firebasejs/9.22.0/firebase-firestore-compat.js"></script>
</head>
<body>
  <div class="container">
    <div class="case-header">
      <a href="#" class="back-link" onclick="goBack(event)">← Back to Cases</a>
    </div>

    <h1>Case 29.8 – Unplanned Pregnancy & Contraception [SDL]</h1>
    <p class="meta"><strong>Category:</strong> Endocrine & Reproductive Symptoms | <strong>Discipline:</strong> Obstetrics & Gynaecology | <strong>Setting:</strong> General Practice</p>

    <h2>Learning Objectives</h2>
    <p>This is a <strong>self-directed learning (SDL)</strong> case. Use the key learning points below to guide your independent study of unplanned pregnancy and emergency contraception.</p>

    <h2>Key Topics to Cover</h2>
    <div class="key-points">
      <ul>
        <li><strong>Epidemiology:</strong> 45% of pregnancies in UK are unplanned, 1 in 3 women will have an abortion by age 45</li>
        <li><strong>Initial assessment (presenting with unplanned pregnancy):</strong>
          <ul>
            <li><strong>Confirm pregnancy:</strong> Urine βhCG (positive 14 days after conception, ~day 28 of cycle), transvaginal USS (gestational sac visible 5 weeks gestation)</li>
            <li><strong>Establish gestational age:</strong> Last menstrual period (LMP), USS dating (crown-rump length &lt;14 weeks)</li>
            <li><strong>Explore options (non-directive counselling):</strong>
              <ul>
                <li><strong>Continue pregnancy:</strong> Antenatal care, adoption if desired</li>
                <li><strong>Abortion:</strong> Medical or surgical (patient choice)</li>
              </ul>
            </li>
            <li><strong>Exclude ectopic pregnancy:</strong> Pain, bleeding, empty uterus on USS, βhCG plateau/slow rise</li>
          </ul>
        </li>
        <li><strong>Emergency contraception (post-unprotected intercourse):</strong>
          <ul>
            <li><strong>1. Copper IUD (Cu-IUD) - MOST EFFECTIVE (\&gt;99% efficacy):</strong>
              <ul>
                <li>Can be inserted up to <strong>5 days after unprotected sexual intercourse (UPSI)</strong> OR up to 5 days after earliest estimated ovulation (whichever is later)</li>
                <li>Mechanism: Prevents implantation (toxic to sperm/ova, prevents fertilization)</li>
                <li>Advantages: Most effective, can be left in situ for ongoing contraception (10 years), no hormonal side effects</li>
                <li>Disadvantages: Invasive procedure, risk of infection (PID), heavier/painful periods</li>
              </ul>
            </li>
            <li><strong>2. Ulipristal acetate (UPA / ellaOne) - SECOND-LINE (98% efficacy if taken within 24 hours):</strong>
              <ul>
                <li>Single oral dose (30mg) - effective up to <strong>120 hours (5 days)</strong> after UPSI</li>
                <li>Mechanism: Selective progesterone receptor modulator → delays/inhibits ovulation</li>
                <li>Advantages: More effective than levonorgestrel (especially 72-120 hours), non-invasive</li>
                <li>Disadvantages: Delayed next period (may cause anxiety), cannot use hormonal contraception for 5 days after (UPA antagonizes progesterone)</li>
                <li><strong>BMI >26 or weight >70kg:</strong> Consider double dose (60mg - off-label) or Cu-IUD (UPA efficacy may be reduced)</li>
              </ul>
            </li>
            <li><strong>3. Levonorgestrel (Levonelle) - THIRD-LINE (95% efficacy if taken within 24 hours):</strong>
              <ul>
                <li>Single oral dose (1.5mg) - effective up to <strong>72 hours (3 days)</strong> after UPSI</li>
                <li>Mechanism: Delays/inhibits ovulation (ineffective if ovulation already occurred)</li>
                <li>Advantages: Available over-the-counter (pharmacy), can start hormonal contraception immediately</li>
                <li>Disadvantages: Less effective than UPA (especially 48-72 hours), efficacy reduced if BMI >26 (consider double dose 3mg or Cu-IUD)</li>
              </ul>
            </li>
            <li><strong>Key counselling:</strong>
              <ul>
                <li><strong>Efficacy decreases with time</strong> - earliest possible administration best</li>
                <li><strong>Not 100% effective</strong> - pregnancy test if period delayed >7 days</li>
                <li><strong>Does NOT protect against future UPSI</strong> - start regular contraception immediately (or use Cu-IUD for ongoing contraception)</li>
                <li><strong>STI risk:</strong> Offer STI screening if unprotected sex</li>
              </ul>
            </li>
          </ul>
        </li>
        <li><strong>Abortion (termination of pregnancy) - Legal Framework:</strong>
          <ul>
            <li><strong>UK law (Abortion Act 1967, amended 1990):</strong>
              <ul>
                <li>Legal up to <strong>24 weeks gestation</strong> if continuing pregnancy involves greater risk to physical/mental health of woman/existing children than termination (Clause C - >98% of abortions)</li>
                <li>Legal up to <strong>term</strong> if: Severe fetal abnormality incompatible with life (Clause E), or grave risk to mother's life/health (Clause B/D)</li>
                <li><strong>Requires 2 doctors to sign HSA1 form</strong> confirming legal grounds</li>
              </ul>
            </li>
            <li><strong>Northern Ireland:</strong> Abortion legal since 2020 (similar to England/Wales)</li>
          </ul>
        </li>
        <li><strong>Methods of abortion:</strong>
          <ul>
            <li><strong>Medical abortion (up to 10 weeks gestation - can be used up to 24 weeks):</strong>
              <ul>
                <li><strong>Regimen:</strong>
                  <ul>
                    <li><strong>Mifepristone 200mg oral</strong> (anti-progesterone → stops pregnancy) - Day 1</li>
                    <li><strong>Misoprostol 800mcg buccal/vaginal</strong> (prostaglandin → induces uterine contractions, expels pregnancy) - 24-48 hours later (Day 2-3)</li>
                  </ul>
                </li>
                <li><strong>Home medical abortion:</strong> Can take both medications at home (up to 10 weeks) - approved 2020 (COVID-19 pandemic), now permanent</li>
                <li><strong>Efficacy:</strong> 95-98% (≤9 weeks), decreases with gestation</li>
                <li><strong>Process:</strong> Bleeding/cramping starts 1-4 hours after misoprostol, pregnancy expelled within 4-6 hours (heavy bleeding 1-2 weeks)</li>
                <li><strong>Follow-up:</strong> Urine pregnancy test 3 weeks later (confirm complete abortion), or USS if ongoing symptoms</li>
                <li><strong>Complications:</strong> Incomplete abortion (2-5% - requires surgical evacuation), infection (1%), ongoing pregnancy (\&lt;1%)</li>
              </ul>
            </li>
            <li><strong>Surgical abortion:</strong>
              <ul>
                <li><strong>Vacuum aspiration (suction curettage) - up to 14 weeks:</strong>
                  <ul>
                    <li>Performed under local anesthetic + sedation or general anesthetic</li>
                    <li>Cervix dilated, suction catheter inserted to evacuate uterus</li>
                    <li>Duration: 5-10 minutes, day case</li>
                    <li>Efficacy: >99%</li>
                  </ul>
                </li>
                <li><strong>Dilation and evacuation (D&E) - 14-24 weeks:</strong>
                  <ul>
                    <li>Cervical preparation (mifepristone + misoprostol 24-48 hours before), then surgical evacuation under general anesthetic</li>
                    <li>More complex procedure, higher complication risk</li>
                  </ul>
                </li>
                <li><strong>Advantages:</strong> Quicker (single visit), predictable timing, less bleeding than medical</li>
                <li><strong>Complications:</strong> Uterine perforation (\&lt;1%), cervical trauma (\&lt;1%), infection (1%), incomplete evacuation (1%)</li>
              </ul>
            </li>
          </ul>
        </li>
        <li><strong>Post-abortion contraception:</strong>
          <ul>
            <li><strong>Start immediately</strong> (fertility returns quickly - ovulation within 2 weeks)</li>
            <li><strong>LARC recommended:</strong> IUD (Cu-IUD or LNG-IUS), implant (Nexplanon), depot injection (Depo-Provera) - highest efficacy, prevent repeat unplanned pregnancy</li>
            <li><strong>Cu-IUD:</strong> Can be inserted immediately after surgical abortion or after medical abortion is complete</li>
            <li><strong>Hormonal contraception:</strong> Can start day of mifepristone (medical abortion) or immediately after surgical abortion</li>
          </ul>
        </li>
        <li><strong>Fraser competence (Gillick competence) - Contraception/abortion in under-16s:</strong>
          <ul>
            <li><strong>Legal framework:</strong> Under-16s can consent to contraception/abortion if <strong>Fraser competent</strong> (without parental consent)</li>
            <li><strong>Fraser criteria (ALL must be met):</strong>
              <ul>
                <li>Young person understands advice and has sufficient maturity to understand implications</li>
                <li>Cannot persuade young person to inform parents or allow clinician to inform parents</li>
                <li>Young person is likely to continue having sex with/without contraception</li>
                <li>Young person's physical/mental health likely to suffer without contraception/abortion</li>
                <li>Young person's best interests require contraception/abortion without parental consent</li>
              </ul>
            </li>
            <li><strong>Safeguarding:</strong> Assess for coercion, abuse, exploitation - follow local safeguarding policies (may need to breach confidentiality if serious risk of harm)</li>
            <li><strong>Encourage parental involvement</strong> but respect young person's confidentiality if Fraser competent</li>
          </ul>
        </li>
        <li><strong>Key ethical/legal principles:</strong>
          <ul>
            <li><strong>Non-directive counselling:</strong> Provide unbiased information on all options (continue pregnancy, abortion, adoption)</li>
            <li><strong>Autonomy:</strong> Patient's decision (not clinician's moral/religious views)</li>
            <li><strong>Confidentiality:</strong> Absolute (unless safeguarding concerns)</li>
            <li><strong>Conscientious objection:</strong> Clinicians can refuse to participate in abortion (Abortion Act 1967 Section 4) BUT must refer to another clinician (cannot obstruct access to care)</li>
          </ul>
        </li>
      </ul>
    </div>

    <h2>Recommended Resources</h2>
    <p>Refer to your lecture notes, textbooks (e.g., Oxford Handbook of Obstetrics & Gynaecology), and online resources (RCOG guidelines, FSRH guidelines, BPAS, MSI Reproductive Choices) to explore these topics in detail.</p>

  </div>

  <!-- JavaScript -->  <script src="../js/firebase-config.js"></script>
  <script src="../js/dark-mode.js"></script>
  <script src="../js/auth.js"></script>
  <script src="../js/user-analytics.js"></script>
  <script src="../js/analytics-integration.js"></script>
  <script src="../js/completion-tracker.js"></script>
  <script src="../js/flag-tracker.js"></script>
  <script src="../js/case-interactions.js"></script>

  <script>
    // Toggle case completion
    function toggleCaseCompletion() {
      if (window.completionTracker) {
        const caseId = window.completionTracker.getCurrentCaseId();
        if (caseId) {
          window.completionTracker.toggleCompletion(caseId);
        
    }
      
    }
    
    }
// Toggle case flag
    function toggleCaseFlag() {
      console.log('toggleCaseFlag() function called');
      console.log('window.flagTracker exists:', !!window.flagTracker);

      if (!window.flagTracker) {
        console.error('window.flagTracker is not defined!');
        alert('Flag tracker not initialized. Please refresh the page.');
        return;
      
    }

      const caseId = window.flagTracker.getCurrentCaseId();
      console.log('Current case ID:', caseId);

      if (!caseId) {
        console.error('Could not get case ID');
        alert('Could not determine case ID');
        return;
      
    }

      console.log('Calling window.flagTracker.toggleCaseFlag with caseId:', caseId);
      window.flagTracker.toggleCaseFlag(caseId);
    
    }

    // Update case flag button state on page load
    document.addEventListener('DOMContentLoaded', () => {
      if (window.flagTracker) {
        setTimeout(() => {
          const caseId = window.flagTracker.getCurrentCaseId();
          if (caseId) {
            window.flagTracker.updateCaseFlagButton(caseId);
          
    }
        }, 100);
      
    }
    });
    
    }
  </script>

</body>
</html>
